Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ibodutant in female IBS-D
NCT02120027Phase 3Terminated
- Sponsor
- Menarini Group
- Start
- Feb 2014
- Primary completion
- Nov 2015
- Modality
- Small Molecules
- Countries
- 9
01
Overview
A Phase 3 trial of ibodutant in Irritable bowel syndrome with diarrhea (IBS-D), sponsored by Menarini Group. Started Feb 2014; status: terminated.
02
Drugs
ibodutant
03
Conditions
Irritable bowel syndrome with diarrhea (IBS-D)
Beyond the preview
Go deeper on NCT02120027.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02120027.